LENZ Therapeutics, Inc. (LENZ) Capital Expenditures (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Capital Expenditures for 2 consecutive years, with $30000.0 as the latest value for Q4 2023.
- On a quarterly basis, Capital Expenditures fell 97.06% to $30000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $30000.0, a 99.55% decrease, with the full-year FY2024 number at $468000.0, up 1460.0% from a year prior.
- Capital Expenditures was $30000.0 for Q4 2023 at LENZ Therapeutics, up from -$30000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $3.3 million in Q1 2022 to a low of -$30000.0 in Q3 2023.